Prognostic Role of Detection Method and Its Relationship with Tumor Biomarkers in Breast Cancer: The University of Texas M. D. Anderson Cancer Center Experience
Open Access
- 1 May 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (5), 1096-1103
- https://doi.org/10.1158/1055-9965.epi-08-0201
Abstract
Purpose: To assess the effect of tumor detection method (screening versus symptom-based diagnosis) in predicting breast cancer survival and investigate how biological features of breast cancer are related to the tumor detection method. Patients and Methods: The study population consisted of 5,481 women diagnosed with primary invasive breast cancer between 1997 and 2005 and received their treatment at The University of Texas M. D. Anderson Cancer Center. Results: Patients with symptom-detected tumors had an increased risk of recurrence or death [relative risk (RR), 1.34; P = 0.006] and breast cancer–specific death (RR, 1.31; P = 0.117) than patients with screen-detected tumors after adjusting for tumor characteristics and treatments received. This relationship was especially evident among estrogen receptor (ER)–negative tumors (RR, 1.60 for breast cancer recurrence for ER-negative tumors; RR, 1.18 for ER-positive tumors). ER status and Ki-67 expression were statistically significantly associated with symptom detection rate after adjusting for patients' age, tumor stage, tumor size, and nuclear grade [odds ratio (OR) of ER negative versus ER positive, 1.35; P < 0.001; OR of Ki-67 10-30% versus 30% versus P < 0.001]. Conclusion: The method of detection was a statistically significant independent predictor of breast cancer recurrence. Information on the method of tumor detection should be collected to improve the prediction of prognosis of breast cancer patients. (Cancer Epidemiol Biomarkers Prev 2008;17(5):1096–103)Keywords
This publication has 24 references indexed in Scilit:
- Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?Breast Cancer Research and Treatment, 2006
- Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: The importance of early detectionBreast Cancer Research and Treatment, 2006
- Role of Detection Method in Predicting Breast Cancer Survival: Analysis of Randomized Screening TrialsJNCI Journal of the National Cancer Institute, 2005
- Should Screen-detected Breast Cancers Be Managed Differently?JNCI Journal of the National Cancer Institute, 2005
- Breast Cancer Screening Comes Full CircleJNCI Journal of the National Cancer Institute, 2004
- Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35Cancer, 2002
- Biologic Characteristics of Interval and Screen-Detected Breast CancersJNCI Journal of the National Cancer Institute, 2000
- Stage-shift cancer screening modelJournal of Clinical Epidemiology, 1989
- Analysis of Breast Cancer Mortality and Stage Distribution by Age for the Health Insurance Plan Clinical TrialJNCI Journal of the National Cancer Institute, 1988
- The Effects of Early Treatment, Lead Time and Length Bias on the Mortality Experienced by Cases Detected by ScreeningInternational Journal of Epidemiology, 1982